Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

Also known as: Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00530Erlotinib3Active Not Recruiting1
DB00317Gefitinib3Active Not Recruiting1
DB00317Gefitinib3Unknown Status1